A phase 1a dose-escalation study of PY159, a monoclonal antibody targeting TREM1 (triggering receptor expressed on myeloid cells 1) von Winer, Ira Seth, Patnaik, Amita, Barve, Minal A., Kummar, Shivaani, Schenk, Erin Lynn, LoRusso, Patricia, Yeku, Oladapo O., Fu, Siqing, Jahchan, Nadine, Myers, Matthew, Liang, Linda, Deegan, Denise, Jackson, Lynnae, Li, Yunfeng, Reyno, Len, Chamberlain, Marc Charles

Volltext

Abstract LB071: Tuning the tumor myeloid microenvironment (TME) by targeting TREM2+ tumor-associated macrophages to overcome resistance to immune checkpoint inhibitors von Jahchan, Nadine S., Binnewies, Mikhail, Pollack, Joshua L., Mehta, Ranna, Dash, Subhadra, Tun, Christine, Lu, Erick, Du, Xiaoyan, Baker, Kevin P., Reyno, Len, Sriram, Venkataraman

Volltext

A phase 1a dose-escalation study of PY314, a TREM2 (Triggering Receptor Expressed on Macrophages 2) targeting monoclonal antibody von Patnaik, Amita, Hamilton, Erika P., Winer, Ira Seth, Tan, Winston, Hubbard, Joleen M., Schenk, Erin Lynn, Sonbol, Mohamad B., Jahchan, Nadine, Pierce, Kristen, Li, Yunfeng, Reyno, Len, Chamberlain, Marc

Volltext

1715/Longitudinal Comparison of Patient's and Caregiver's Psychological Morbidity during End-of-Life Care for Breast Cancer von Grunfeld, Eva, Jennifer Clinch, Teresa Janz, Timothy Whelan, Len Reyno, Craig Earle, Robert Glossop, Willan, Andrew

Volltext